Epigenetic actions of melatonin

Journal of Pineal Research

Volumn 46, Issue 1, 2009, Pages 117-118

  Korkmaz, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; MELATONIN; MELATONIN RECEPTOR; RNA POLYMERASE; HISTONE; HISTONE DEACETYLASE; RETINOID X RECEPTOR;

CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; LETTER; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; HUMAN; METABOLISM;

CYCLIN D1; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; MELATONIN; RETINOID X RECEPTORS;

EID: 57149147999     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00613.x     Document Type: Letter

References (15)

1. Sharma R, Ottenhof T, Rzeczkowska PA et al. Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. J Pineal Res 2008 doi :.
2. Miremadi A, Oestergaard MZ, Pharoah PD et al. Cancer genetics of epigenetic genes. Hum Mol Genet 2007 16 : 28 49.
3. Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res 2008 44 : 41 44.
4. Zechel C. Requirement of retinoic acid receptor isotypes alpha, beta, and gamma during the initial steps of neural differentiation of PCC7 cells. Mol Endocrinol 2005 19 : 1629 1645.
5. Park HT, Kim YJ, Yoon S et al. Distributional characteristics of the mRNA for retinoid Z receptor beta (RZR beta), a putative nuclear melatonin receptor, in the rat brain and spinal cord. Brain Res 1997 747 : 332 337.
6. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000 14 : 121 141.
7. Lonard DM, Lanz RB, O'malley BW. Nuclear receptor coregulators and human disease. Endocr Rev 2007 28 : 575 587.
8. Cicatiello L, Addeo R, Sasso A et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 2004 24 : 7260 7274.
9. De Los Santos M, Martinez-Iglesias O, Aranda A. Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells. Endocr Relat Cancer 2007 14 : 1021 1028.
10. Cini G, Neri B, Pacini A et al. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. J Pineal Res 2005 39 : 12 20.
11. Siu SW, Lau KW, Tam PC et al. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002 52 : 106 122.
12. Leon-Blanco MM, Guerrero JM, Reiter RJ et al. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 2003 35 : 204 211.
13. Leon-Blanco MM, Guerrero JM, Reiter RJ et al. RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line. Cancer Lett 2004 216 : 73 80.
14. Guilleret I, Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 2003 289 : 326 334.
15. Deng WG, Tang ST, Tseng HP et al. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 2006 108 : 518 524.